New Precision Cancer Treatment Starts First Human Trials in Europe for Aggressive Pancreatic Cancer
A Swedish biotech company called Anocca has started the first tests in humans of a new experimental cancer treatment called […]
Pharmaceutical News
New Treatment Shows Promise for People with Moderate to Severe Lupus in Clinical Trial
Johnson & Johnson recently shared early results from a clinical trial (called the JASMINE study) that tested a new medication
Pharmaceutical News
Takeda Reports $950 Million Loss After U.S. Court Ruling on Drug Delay Practices
A recent court decision in the United States has forced Japanese drugmaker Takeda to report a significant financial loss for
Pharmaceutical News
New Study Raises Concerns About Side Effects of Cancer Drug Zynlonta
A recent clinical trial for Zynlonta, a medication used to treat a type of blood cancer called diffuse large B-cell
Pharmaceutical News
Pharmaceutical Company Axsome Secures Extended Protection for Sleep Disorder Medication Sunosi, Delaying Generic Competition Until 2040
A pharmaceutical company called Axsome Therapeutics has reached a legal agreement that will prevent other companies from selling cheaper, generic
New immunotherapy treatment helps bladder cancer patients avoid surgery and stay cancer-free
A recent clinical trial has found that adding a new immunotherapy drug called durvalumab to traditional chemotherapy and radiation therapy
Pharmaceutical News
New EU Rules to Better Assess Chemical Safety for Health and Environment
Starting January 1st, the European Union has introduced new laws to improve how chemicals are evaluated for safety. This is
Pharmaceutical News
Pfizer and Innovent Biologics Join Forces to Develop New Cancer Treatments Worth Up to $10.5 Billion
Leading pharmaceutical companies Pfizer and Innovent Biologics have signed a major agreement to work together on developing 12 new cancer
New Study Finds Bimekizumab More Effective Than Risankizumab for Psoriatic Arthritis
UCB, a pharmaceutical company, has shared new results from a major clinical trial called the BE BOLD study. The trial
New Hope for Patients with a Specific Type of Advanced Bowel Cancer: European Medicines Agency Recommends Approval of a Targeted Treatment Combination
Pierre Fabre Laboratories has received a positive recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human